Humans could be tested to see if they have a risk factor for Parkinson’s disease, the progressive, incurable neurodegenerative disorder that affects 1.5 million Americans and receive preventive treatment. The study demonstrates that high levels of MAO-B, an enzyme that regulates nerve activity in the brain, cause Parkinson’s-like symptoms in mice genetically engineered to overexpress the protein.